Los Angeles Capital Management LLC Grows Stock Position in Healthpeak Properties, Inc. (NYSE:PEAK)

Posted by Defense World Staff on May 3rd, 2023

Los Angeles Capital Management LLC increased its position in Healthpeak Properties, Inc. (NYSE:PEAK – Get Rating) by 7.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,408 shares of the company’s stock after acquiring an additional 2,825 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Healthpeak Properties were worth $1,013,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SG Americas Securities LLC increased its holdings in Healthpeak Properties by 362.5% in the 4th quarter. SG Americas Securities LLC now owns 58,214 shares of the company’s stock worth $1,459,000 after acquiring an additional 45,628 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in Healthpeak Properties by 270.8% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,294 shares of the company’s stock worth $30,000 after acquiring an additional 945 shares in the last quarter. Macquarie Group Ltd. increased its holdings in Healthpeak Properties by 26.4% in the 3rd quarter. Macquarie Group Ltd. now owns 2,216,061 shares of the company’s stock worth $51,084,000 after acquiring an additional 462,731 shares in the last quarter. Asset Management One Co. Ltd. increased its holdings in Healthpeak Properties by 7.0% in the 4th quarter. Asset Management One Co. Ltd. now owns 1,215,167 shares of the company’s stock worth $30,621,000 after acquiring an additional 79,931 shares in the last quarter. Finally, Zacks Investment Management increased its holdings in Healthpeak Properties by 3.6% in the 3rd quarter. Zacks Investment Management now owns 1,131,858 shares of the company’s stock worth $25,943,000 after acquiring an additional 39,622 shares in the last quarter. 92.04% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Sara Grootwassink Lewis purchased 4,000 shares of the business’s stock in a transaction dated Wednesday, March 15th. The shares were purchased at an average price of $21.43 per share, for a total transaction of $85,720.00. Following the completion of the purchase, the director now owns 4,000 shares in the company, valued at approximately $85,720. The purchase was disclosed in a document filed with the SEC, which is available at this link. In other news, COO Thomas Klaritch purchased 1,517 shares of the business’s stock in a transaction dated Tuesday, March 7th. The shares were purchased at an average price of $23.21 per share, for a total transaction of $35,209.57. Following the completion of the purchase, the chief operating officer now owns 344,000 shares in the company, valued at approximately $7,984,240. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Sara Grootwassink Lewis purchased 4,000 shares of the business’s stock in a transaction dated Wednesday, March 15th. The shares were purchased at an average price of $21.43 per share, for a total transaction of $85,720.00. Following the purchase, the director now owns 4,000 shares of the company’s stock, valued at approximately $85,720. The disclosure for this purchase can be found here. Insiders have acquired a total of 21,817 shares of company stock worth $506,099 over the last quarter. Company insiders own 0.19% of the company’s stock.

Healthpeak Properties Stock Performance

PEAK stock opened at $21.18 on Wednesday. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.90. The business’s fifty day simple moving average is $21.95 and its two-hundred day simple moving average is $24.24. Healthpeak Properties, Inc. has a twelve month low of $20.21 and a twelve month high of $33.42. The firm has a market cap of $11.59 billion, a price-to-earnings ratio of 20.97, a PEG ratio of 3.13 and a beta of 0.89.

Healthpeak Properties (NYSE:PEAK – Get Rating) last released its earnings results on Tuesday, February 7th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.42). Healthpeak Properties had a return on equity of 7.76% and a net margin of 26.17%. The business had revenue of $524.47 million during the quarter, compared to analysts’ expectations of $518.85 million. During the same quarter in the previous year, the business earned $0.41 EPS. The business’s revenue for the quarter was up 8.5% on a year-over-year basis. Analysts predict that Healthpeak Properties, Inc. will post 1.73 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 19th. Shareholders of record on Monday, May 8th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, May 5th. This represents a $1.20 dividend on an annualized basis and a yield of 5.67%. Healthpeak Properties’s payout ratio is 118.81%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on PEAK shares. Scotiabank lowered shares of Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and set a $24.00 target price for the company. in a report on Friday, March 31st. TheStreet lowered shares of Healthpeak Properties from a “b-” rating to a “c+” rating in a report on Tuesday, February 21st. Stifel Nicolaus cut their price objective on shares of Healthpeak Properties from $34.00 to $30.00 in a report on Friday, April 28th. Mizuho raised shares of Healthpeak Properties from a “neutral” rating to a “buy” rating and cut their price objective for the company from $29.00 to $25.00 in a report on Monday, April 24th. Finally, Morgan Stanley increased their price objective on shares of Healthpeak Properties from $23.00 to $25.00 and gave the company an “equal weight” rating in a report on Friday, March 10th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $27.77.

About Healthpeak Properties

(Get Rating)

Healthpeak Properties, Inc is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community (CCRC). The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry.